Briefings in Bioinformatics,
Journal Year:
2022,
Volume and Issue:
23(4)
Published: July 5, 2022
Abstract
Complex
biomedical
data
generated
during
clinical,
omics
and
mechanism-based
experiments
have
increasingly
been
exploited
through
cloud-
visualization-based
mining
techniques.
However,
the
scientific
community
still
lacks
an
easy-to-use
web
service
for
comprehensive
visualization
of
data,
particularly
high-quality
publication-ready
graphics
that
allow
easy
scaling
updatability
according
to
user
demands.
Therefore,
we
propose
a
community-driven
modern
service,
Hiplot
(https://hiplot.org),
with
concise
top-quality
applications
life
sciences
fields.
This
permits
users
conveniently
interactively
complete
few
specialized
tasks
previously
could
only
be
conducted
by
senior
bioinformatics
or
biostatistics
researchers.
It
covers
most
daily
demands
researchers
its
equipped
240+
functions,
involving
basic
statistics,
multi-omics,
regression,
clustering,
dimensional
reduction,
meta-analysis,
survival
analysis,
risk
modelling,
etc.
Moreover,
improve
efficiency
in
use
development
plugins,
introduced
some
core
advantages
on
client-/server-side
website,
such
as
spreadsheet-based
importing,
cross-platform
command-line
controller
(Hctl),
multi-user
plumber
workers,
JavaScript
Object
Notation-based
plugin
system,
data/parameters,
results
errors
reproduction
real-time
updates
mode.
Meanwhile,
using
demo/real
sets
benchmark
tests,
explored
statistical
parameters,
cancer
genomic
landscapes,
disease
factors
performance
website
based
selected
native
plugins.
The
statistics
visits
numbers
further
reflect
potential
impact
this
relevant
Thus,
devoted
would
benefit
from
emerging
free
service.
Nucleic Acids Research,
Journal Year:
2020,
Volume and Issue:
48(W1), P. W509 - W514
Published: May 17, 2020
Abstract
Tumor
progression
and
the
efficacy
of
immunotherapy
are
strongly
influenced
by
composition
abundance
immune
cells
in
tumor
microenvironment.
Due
to
limitations
direct
measurement
methods,
computational
algorithms
often
used
infer
cell
from
bulk
transcriptome
profiles.
These
estimated
infiltrate
populations
have
been
associated
with
genomic
transcriptomic
changes
tumors,
providing
insight
into
tumor–immune
interactions.
However,
such
investigations
on
large-scale
public
data
remain
challenging.
To
lower
barriers
for
analysis
complex
interactions,
we
significantly
improved
our
previous
web
platform
TIMER.
Instead
just
using
one
algorithm,
TIMER2.0
(http://timer.cistrome.org/)
provides
more
robust
estimation
infiltration
levels
The
Cancer
Genome
Atlas
(TCGA)
or
user-provided
profiles
six
state-of-the-art
algorithms.
four
modules
investigating
associations
between
infiltrates
genetic
clinical
features,
exploring
cancer-related
TCGA
cohorts.
Each
module
can
generate
a
functional
heatmap
table,
enabling
user
easily
identify
significant
multiple
cancer
types
simultaneously.
Overall,
server
comprehensive
visualization
functions
infiltrating
cells.
Journal of Hematology & Oncology,
Journal Year:
2020,
Volume and Issue:
13(1)
Published: Aug. 10, 2020
Abstract
In
recent
years,
cancer
immunotherapy
based
on
immune
checkpoint
inhibitors
(ICIs)
has
achieved
considerable
success
in
the
clinic.
However,
ICIs
are
significantly
limited
by
fact
that
only
one
third
of
patients
with
most
types
respond
to
these
agents.
The
induction
cell
death
mechanisms
other
than
apoptosis
gradually
emerged
as
a
new
treatment
strategy
because
tumors
harbor
innate
resistance
apoptosis.
date,
possibility
combining
two
modalities
not
been
discussed
systematically.
Recently,
few
studies
revealed
crosstalk
between
distinct
and
antitumor
immunity.
pyroptosis,
ferroptosis,
necroptosis
combined
showed
synergistically
enhanced
activity,
even
ICI-resistant
tumors.
Immunotherapy-activated
CD8+
T
cells
traditionally
believed
induce
tumor
via
following
main
pathways:
(i)
perforin-granzyme
(ii)
Fas-FasL.
identified
mechanism
which
suppress
growth
inducing
ferroptosis
provoked
review
relationship
system
activation.
Hence,
this
review,
we
summarize
knowledge
reciprocal
interaction
immunity
mechanisms,
particularly
necroptosis,
three
potentially
novel
immunogenic
death.
Because
evidence
is
derived
from
using
animal
models,
also
reviewed
related
bioinformatics
data
available
for
human
tissues
public
databases,
partially
confirmed
presence
interactions
activation
Advanced Science,
Journal Year:
2020,
Volume and Issue:
7(7)
Published: Feb. 11, 2020
The
distribution
and
abundance
of
immune
cells,
particularly
T-cell
subsets,
play
pivotal
roles
in
cancer
immunology
therapy.
T
cells
have
many
subsets
with
specific
function
current
methods
are
limited
estimating
them,
thus,
a
method
for
predicting
comprehensive
is
urgently
needed
research.
Here,
Immune
Cell
Abundance
Identifier
(ImmuCellAI),
gene
set
signature-based
method,
introduced
precisely
the
24
cell
types
including
18
from
expression
data.
Performance
evaluation
on
both
sequencing
data
flow
cytometry
results
public
indicate
that
ImmuCellAI
can
estimate
superior
accuracy
to
other
especially
subsets.
Application
immunotherapy
datasets
reveals
dendritic
cytotoxic
T,
gamma
delta
significantly
higher
comparisons
on-treatment
versus
pre-treatment
responders
non-responders.
Meanwhile,
an
result-based
model
built
response
high
(area
under
curve
0.80-0.91).
These
demonstrate
powerful
unique
tumor
infiltration
estimation
prediction.
Nature Communications,
Journal Year:
2020,
Volume and Issue:
11(1)
Published: Feb. 21, 2020
Abstract
Long
noncoding
RNAs
(lncRNAs)
are
emerging
as
critical
regulators
of
gene
expression
and
they
play
fundamental
roles
in
immune
regulation.
Here
we
introduce
an
integrated
algorithm,
ImmLnc,
for
identifying
lncRNA
immune-related
pathways.
We
comprehensively
chart
the
landscape
regulation
immunome
across
33
cancer
types
show
that
cancers
with
similar
tissue
origin
likely
to
share
regulators.
Moreover,
lncRNAs
perturbation
significantly
correlated
cell
infiltration.
ImmLnc
can
help
prioritize
cancer-related
further
identify
three
molecular
subtypes
(proliferative,
intermediate,
immunological)
non-small
lung
cancer.
These
characterized
by
differences
mutation
burden,
infiltration,
immunomodulatory
genes,
response
chemotherapy,
prognosis.
In
summary,
pipeline
resulting
data
serve
a
valuable
resource
understanding
function
advance
identification
immunotherapy
targets.
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: Nov. 4, 2022
Abstract
Cancer-associated
fibroblasts
(CAFs)
are
the
predominant
components
of
tumor
microenvironment
(TME)
and
influence
cancer
hallmarks,
but
without
systematic
investigation
on
their
ubiquitous
characteristics
across
different
types.
Here,
we
perform
pan-cancer
analysis
226
samples
10
solid
types
to
profile
TME
at
single-cell
resolution,
illustrating
commonalities/plasticity
heterogenous
CAFs.
Activation
trajectory
major
CAF
is
divided
into
three
states,
exhibiting
distinct
interactions
with
other
cell
components,
relating
prognosis
immunotherapy.
Moreover,
minor
represent
alternative
origin
from
(e.g.,
endothelia
macrophages).
Particularly,
presentation
endothelial-to-mesenchymal
transition
CAF,
which
may
interact
proximal
SPP
1
+
tumor-associated
macrophages,
implicated
in
survival
stratifications.
Our
study
comprehensively
profiles
shared
dynamics
CAFs,
highlight
heterogeneity
plasticity
Browser
integrated
information
available
https://gist-fgl.github.io/sc-caf-atlas/
.
Frontiers in Immunology,
Journal Year:
2019,
Volume and Issue:
10
Published: Jan. 28, 2019
Background:
Layilin
(LAYN)
is
a
critical
gene
that
regulates
T
cell
function.
However,
the
correlations
of
LAYN
to
prognosis
and
tumor-infiltrating
lymphocytes
in
different
cancers
remain
unclear.
Methods:
expression
was
analyzed
via
Oncomine
database
Tumor
Immune
Estimation
Resource
(TIMER)
site.
We
evaluated
influence
on
clinical
using
Kaplan-Meier
plotter,
PrognoScan
Gene
Expression
Profiling
Interactive
Analysis
(GEPIA).
The
between
cancer
immune
infiltrates
investigated
TIMER.
In
addition,
marker
sets
were
by
TIMER
GEPIA.
Results:
A
cohort
(GSE17536)
colorectal
patients
showed
high
associated
with
poorer
overall
survival
(OS),
disease-specific
(DSS)
disease-free
(DFS).
significantly
correlated
poor
OS
progression-free
(PFS)
gastric
(OS
HR
=
1.97,
P
3.6e-10;
PFS
2.12,
2.3e-10).
Moreover,
LYAN
impacts
diverse
Cancer
Genome
Atlas
(TCGA).
Specifically,
worse
stage
2
4
but
not
1
N0
(P
0.28,
0.34;
0.073,
0.092).
positively
infiltrating
levels
CD4+
CD8+
cells,
macrophages,
neutrophils
dendritic
cells
(DCs)
colon
adenocarcinoma
(COAD)
stomach
(STAD).
strong
COAD
STAD.
Conclusions:
These
findings
suggest
of,
including
those
DCs
multiple
cancers,
especially
patients.
potentially
contributes
regulation
tumor-associated
macrophages
(TAMs),
DCs,
exhaustion
Tregs
cancer.
can
be
used
as
prognostic
biomarker
for
determining
infiltration
cancers.